Table 3

Range of Borrelia burgdorferi sensu lato (Bb) seroprevalence in five populations from different continents

ContinentGeneral populationHigh-risk populationTick-bitten populationLB-like symptoms populationAll
America
North America1.2% (0.0%–5.4%)27.8% (4.6%–60.8%)30.4% (0.9%–77.2%)14.2% (12.4%–16.2%)9.4% (2.6%–19.8%)
South America4.6% (1.9%–8.5%)12.2% (1.8%–29.9%)8.7% (3.2%–16.6%)
Europe
Southern Europe4.4% (2.1%–6.8%)12.3% (6.4%–16.9%)11.1% (5.2%–18.8%)
Western Europe7.5% (5.2%–10.1%)13.1% (1.7%–32.7%)23.2% (6.1%–46.9%)47.9% (34.3%–61.6%)13.5% (9.5%–18.0%)
Northern Europe8.6% (5.3%–12.6%)9.3% (7.6%–11.1%)3.2% (1.6%–5.4%)14.3% (5.5%–26.3%)7.6% (4.3%–11.7%)
Eastern Europe4.8% (3.4%–6.5%)10.7% (7.8%–13.9%)35.5% (27.3%–44.1%)10.4% (5.3%–16.9%)
Central Europe10.9% (8.8%–13.2%)35.7% (23.0%–49.4%)5.5% (2.2%–10.1%)11.2% (6.6%–16.8%)20.7% (13.8%–28.6%)
Asia
Eastern Asia22.5% (14.1%–32.2%)71.4% (46.0%–91.2%)11.1% (7.5%–15.7%)15.9% (6.6%–28.3%)
Southern Asia3.0% (1.6%–4.7%)3.0% (1.6%–4.7%)
Western Asia5.2% (1.5%–10.9%)7.8% (1.6%–18.2%)17.1% (9.5%–26.3%)6.3% (2.3%–12.2%)
Caribbean2.0% (0.6%–4.1%)2.0% (0.6%–4.1%)
Oceania0.0% (0.0%–21.5%)4.1% (0.4%–15.4%)
All5.7% (4.3%–7.3%)14.7% (9.7%–19.5%)18.8% (10.1%–29.4%)21.3% (14.1%–29.4%)11.3% (9.2%–13.6%)
  • LB, Lyme borreliosis.